Literature DB >> 30182245

Health services research in German radiation oncology: new opportunities to advance cancer care.

Daniel Medenwald1,2, Christian T Dietzel3, Dirk Vordermark3.   

Abstract

BACKGROUND: Health services research (HSR) is of increasing relevance to scientists, health-care providers, and clinicians. Complex population-based secondary data are a key source of information for analyses of health-care effects in radiation oncology.
METHODS: In this short paper, we examine potential applications of secondary data focusing on statistics from the diagnosis-related groups (DRG). This data set incorporating all hospitalized cases in Germany is based on claims of reimbursements and is provided by the Research Data Centers (RDC) of the Federal Statistical Office and the Statistical Offices of the federal states. A short outlook regarding other data sources is also presented.
RESULTS: In radiation oncology, secondary data such as the DRG statistics have rarely been used to examine health-care effects, despite their great potential for reporting effects in a broad population-based setting. Furthermore, for most data sources, the application to use these data is accessible with minor effort. However, data concerning outpatient care are difficult to analyze on a comparable level.
CONCLUSION: DRG statistics and related secondary data provide a remarkable source of information for analyses of health-care-related effects in radiation oncology.

Entities:  

Keywords:  Cancer registries; German diagnosis-related groups; Health economics; Population; Reimbursement

Mesh:

Year:  2018        PMID: 30182245     DOI: 10.1007/s00066-018-1357-4

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  17 in total

1.  Health economics in radiation oncology: introducing the ESTRO HERO project.

Authors:  Yolande Lievens; Cai Grau
Journal:  Radiother Oncol       Date:  2012-02-08       Impact factor: 6.280

2.  The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines.

Authors:  Geoff Delaney; Susannah Jacob; Carolyn Featherstone; Michael Barton
Journal:  Cancer       Date:  2005-09-15       Impact factor: 6.860

3.  How many new cancer patients in Europe will require radiotherapy by 2025? An ESTRO-HERO analysis.

Authors:  Josep M Borras; Yolande Lievens; Michael Barton; Julieta Corral; Jacques Ferlay; Freddie Bray; Cai Grau
Journal:  Radiother Oncol       Date:  2016-02-24       Impact factor: 6.280

4.  ÖGRO survey on radiotherapy capacity in Austria : Status quo and estimation of future demands.

Authors:  Brigitte Zurl; Anja Bayerl; Alexander De Vries; Hans Geinitz; Robert Hawliczek; Tomas-Henrik Knocke-Abulesz; Peter Lukas; Richard Pötter; Wolfgang Raunik; Brigitte Scholz; Annemarie Schratter-Sehn; Felix Sedlmayer; Dietmar Seewald; Edgar Selzer; Karin S Kapp
Journal:  Strahlenther Onkol       Date:  2017-12-08       Impact factor: 3.621

5.  Evidence-based optimal number of radiotherapy fractions for cancer: A useful tool to estimate radiotherapy demand.

Authors:  Karen Wong; Geoff P Delaney; Michael B Barton
Journal:  Radiother Oncol       Date:  2015-12-21       Impact factor: 6.280

6.  Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.

Authors:  Justin E Bekelman; Scott D Halpern; Carl Rudolf Blankart; Julie P Bynum; Joachim Cohen; Robert Fowler; Stein Kaasa; Lukas Kwietniewski; Hans Olav Melberg; Bregje Onwuteaka-Philipsen; Mariska Oosterveld-Vlug; Andrew Pring; Jonas Schreyögg; Connie M Ulrich; Julia Verne; Hannah Wunsch; Ezekiel J Emanuel
Journal:  JAMA       Date:  2016-01-19       Impact factor: 56.272

7.  Patterns of care in patients with cervical cancer 2012: results of a survey among German radiotherapy departments and out-patient health care centers.

Authors:  S Marnitz; C Köhler; A Rauer; A Schneider; V Budach; A Tsunoda; M Mangler
Journal:  Strahlenther Onkol       Date:  2013-07-27       Impact factor: 3.621

8.  The use of IMRT in Germany.

Authors:  Thorsten Frenzel; Andreas Krüll
Journal:  Strahlenther Onkol       Date:  2015-03-22       Impact factor: 3.621

9.  Reimbursement of radiotherapy in Germany.

Authors:  H Schmidberger
Journal:  Cancer Radiother       Date:  2017-09-01       Impact factor: 1.018

10.  Use of Multicenter Data in a Large Cancer Registry for Evaluation of Outcome and Implementation of Novel Concepts.

Authors:  Gabriele Schubert-Fritschle; Stephanie E Combs; Thomas Kirchner; Volkmar Nüssler; Jutta Engel
Journal:  Front Oncol       Date:  2017-09-29       Impact factor: 6.244

View more
  2 in total

1.  Cost effectiveness and health-related quality of life of chemoradiotherapy versus radiation therapy alone in elderly head and neck cancer patients.

Authors:  Tanja Sprave; Vivek Verma; Alexander Fabian; Alexander Rühle; Dimos Baltas; Anca-Ligia Grosu; Nils H Nicolay
Journal:  Strahlenther Onkol       Date:  2022-07-14       Impact factor: 4.033

2.  Trends in Treatment of Head and Neck Cancer in Germany: A Diagnosis-Related-Groups-Based Nationwide Analysis, 2005-2018.

Authors:  Isabel Hermanns; Rafat Ziadat; Peter Schlattmann; Orlando Guntinas-Lichius
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.